Navigation Links
Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.

The U.S. Food and Drug Administration (FDA) have approved the drug Femara (letrozole) as drug for the treatment of patients suffering from breast cancer among post menopausal women//.

Various studies have been done before the approval of the drug. The result of these studies was published in the December 29 issue of New England Journal of Medicine.

It said that the Novartis drug Femara was very efficient in controlling the recurrence of breast cancer among post menopausal women.

This drug has to be given in the initial therapy after surgery instead of Tamoxifen. This drug is of great importance to both the patients and the clinicians.

The drug is an aromatase inhibitor and prevents/inhibits the production of estrogen hormone. This hormone is the main culprit in inducing post menopausal breast cancers.

This drug is a boon and very useful to all these women suffering from breast cancers which have spread to the lymph nodes and also for women who are done with their chemotherapy.

The main point to be clearly understood by both the patients and clinicians is that the drug has to be prescribed only to postmenopausal women. The reason being that the drug is only effective in these women. If taken by other women will result in fetal damage.

The company has already clearly outlined its side effects which are night sweats, weight gain, joint pain and hot flashes.

This drug is here to stay and help in the treatment of post menopausal breast cancers and advanced breast cancers.


'"/>




Page: 1

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Wonder drug - could end in disaster
3. Have You Ever Wondered How We Perceive Different Sounds?
4. Soy Not Such A Wonder For Health?
5. Have You Ever Wondered Why Male And Female Voices Differ?
6. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
7. Wonder drug Dasatinib gives hopes to leukemia patients
8. Braces Work Wonders In Setting Crooked Teeth Right
9. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
10. Save Budhia - The Indian Wonder Kid
11. Wonder Drug For Weight Loss Launched In UK
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... 05, 2016 , ... Francisco Canales, MD and Heather Furnas, ... Valley office. The technique utilizes the body’s own healing abilities to quickly rejuvenate ... are part of only a select few cosmetic surgeons bringing this procedure to ...
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active ... Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division ... completed his first three-year term as chief and began a second three-year term in ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... PROSHRED franchises from across the country gathered at the La Valencia Hotel in ... performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking away ...
(Date:2/5/2016)... ... 05, 2016 , ... Give To Cure today announced that it ... to Give To Cure’s campaign that is crowdfunding clinical trials to help find cures ... payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... and CEO, will be presenting at Source Capital Group,s 2016 ... NY at 2:15 p.m. ET on Wednesday, February ... Panel discussion taking place at 3:15 p.m. ET. ... one hour after the conclusion of the live event. The ...
(Date:2/5/2016)... , February 5, 2016 ... Market Research report states that the global active pharmaceuticals ... and is predicted to reach US$185.9 bn by 2020. ... 6.50% from 2014 to 2020. The title of the ... Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology: